Rare diseases
Investigational molecules
Locations
Back to Czechia1 217 clinical trials in Prague, Czechia across 18 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)CzechiaStudy on PF-07220060, Letrozole, and Fulvestrant for Patients with Advanced Breast Cancer, Prostate Cancer, and Other Solid Tumors
CzechiaStudy on the Effectiveness and Safety of Guselkumab for Patients with Moderate to Severe Ulcerative Colitis
CzechiaStudy on Long-term Safety of Seralutinib for Patients with Pulmonary Arterial Hypertension
CzechiaStudy Comparing Savolitinib and Durvalumab with Sunitinib and Durvalumab for Patients with Advanced Papillary Renal Cell Carcinoma
CzechiaStudy Comparing Lorlatinib and Crizotinib for Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer
CzechiaStudy of Lenvatinib for Children and Young Adults with Relapsed or Refractory Solid Tumors, Including High Grade Glioma and Rhabdomyosarcoma
CzechiaStudy on the Long-term Safety and Efficacy of Ralinepag for Patients with Pulmonary Arterial Hypertension
CzechiaStudy on the Tolerability and Efficacy of Asciminib vs. Nilotinib for Adults with Newly Diagnosed Philadelphia Chromosome Positive Chronic Myeloid Leukemia
CzechiaStudy on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease
CzechiaCzechiaStudy of Capivasertib and Abiraterone for Patients with Metastatic Hormone-Sensitive Prostate Cancer with PTEN Deficiency
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on TTR amyloidosis and heart disease treatments, alongside studies investigating hypertriglyceridemia management with novel therapeutics.
Multiple trials evaluating new therapeutic approaches for heart failure prevention and treatment.
Comprehensive studies in prostate cancer and multiple myeloma, with particular focus on metastatic conditions and novel treatment combinations.
Advanced trials comparing innovative therapies against standard treatments in various cancer types.
Extensive vaccine development programs including meningococcal and chickenpox vaccines, alongside studies in immune system disorders.
Focus on immunogenicity and safety in various age groups from infants to adults.
Research into chronic rhinosinusitis and COPD, along with studies on inflammatory bowel conditions.
Evaluating new therapeutic approaches for chronic respiratory and inflammatory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
